跳至主要内容
临床试验/CTRI/2018/01/011373
CTRI/2018/01/011373尚未招募未知

A randomized controlled trial comparing the efficacy and safety profile of oral versus subcutaneous route of methotrexate administration in moderate to severe psoriasis - METOS

Postgraduate Institute of Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients aged more than 18 years with clinical diagnosis of plaque psoriasis
  • 2)Patients with body surface area involvement > 10 %, PASI >10,

排除标准

  • 1)Hemoglobin < 8 gm/dl ,Total leukocyte count < 3500/ mm3, Platelet count < 100,000/mm3
  • 2)Elevation of hepatic enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], or γ glutamyl transferase [GGT]) to more than twice the upper limit of normal.
  • 3)Hepatitis, active or recurrent, cirrhosis or excessive current alcohol intake .
  • 4)Use of other hepatotoxic drugs by the patient
  • 5)Positive hepatitis B, hepatitis C or HIV serology
  • 6)Pulmonary or extra-pulmonary active tuberculosis
  • 7)Deranged renal function test.
  • 8)Pregnancy or lactation or if patient is planning to conceive during the treatment period.
  • 9)Patient on other immunosuppressive drugs
  • 10)Recent live vaccination
  • 11)Unreliable patient
  • 12)Patients unwilling for monthly follow-ups.

研究者

相似试验